Latest Intelligence
South Korea's HLB Pep wins $500,000 clinical API manufacturing contract
Kentucky maintains compounding restrictions on six peptides despite federal policy
China's Nankai Hecheng begins trial production of peptide synthesis resins
UAE tightens sourcing and traceability rules for peptide imports
US removes WuXi AppTec from military-company list
Featured Analysis
Samsung's peptide ambitions: Why the Korean giant is betting $1.8 billion on PolyPeptide
Samsung has spent the past decade proving it can turn pharmaceutical manufacturing into an industrial powerhouse. Now it's bringing that ambition — and its financial firepower — to peptides.
READ THE ANALYSIS →